Iraqi Journal of Hematology
Wolters Kluwer Medknow Publications
About the journal
Iraqi Journal of Hematology is an open-access journal published by Wolters Kluwer Medknow Publications in India, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wolters Kluwer Medknow Publications
- ISSN
- 2072-8069 · 2543-2702
- Country
- India
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 361
- Declared review time
- 19 weeks
- Declared peer-review model
- double_blind
- Official website
- https://journals.lww.com/ijhm/Pages/default.aspx
Index listings
- DOAJ · 2018-05-16
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 19 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
361
Most recent article
7 months ago
Average review time (journal-declared via DOAJ)
19weeks
Works in OpenAlex
398
Last recorded publication year
2026
h-index
10
i10-index
12
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2024-08-08
- Added to DOAJ
- 2018-05-16
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- IJHAl-mağallaẗ al-ʿirāqiyyaẗ li-amrāḍ al-damm
- Source type
- journal
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Lymphoma Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Blood groups and transfusion
- Hematological disorders and diagnostics
Show all subjects (75)
- Iron Metabolism and Disorders
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Platelet Disorders and Treatments
- Iron Metabolism and Disorders
- Iron Metabolism and Disorders
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Blood groups and transfusion
- Blood groups and transfusion
- Retinoids in leukemia and cellular processes
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Blood transfusion and management
- Hematological disorders and diagnostics
- Hematological disorders and diagnostics
- Platelet Disorders and Treatments
- Platelet Disorders and Treatments
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Hemophilia Treatment and Research
- Blood donation and transfusion practices
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Blood Coagulation and Thrombosis Mechanisms
- Multiple Myeloma Research and Treatments
- Viral-associated cancers and disorders
- Clinical Laboratory Practices and Quality Control
- Protein Tyrosine Phosphatases
- Blood donation and transfusion practices
- Immunodeficiency and Autoimmune Disorders
- Blood transfusion and management
- Blood properties and coagulation
- Blood donation and transfusion practices
- Complement system in diseases
- Immunodeficiency and Autoimmune Disorders
- Blood properties and coagulation
- Blood transfusion and management
- Blood properties and coagulation
- Inflammatory Biomarkers in Disease Prognosis
- Hematopoietic Stem Cell Transplantation
- Hemophilia Treatment and Research
- Eosinophilic Disorders and Syndromes
- Hemophilia Treatment and Research
- Malaria Research and Control
- Eosinophilic Disorders and Syndromes
- Hematopoietic Stem Cell Transplantation
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Viral-associated cancers and disorders
- COVID-19 Clinical Research Studies
- Hematopoietic Stem Cell Transplantation
- Viral-associated cancers and disorders
- Childhood Cancer Survivors' Quality of Life
- Venous Thromboembolism Diagnosis and Management
- Neutropenia and Cancer Infections
- Childhood Cancer Survivors' Quality of Life
- COVID-19 Clinical Research Studies
- Venous Thromboembolism Diagnosis and Management
- Neutropenia and Cancer Infections
Keywords (DOAJ)
- hematology
- internal medicine
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ